Blocking the CD28/B7 and/or CD154/CD40 costimulatory pathways promotes long
-term allograft survival in many transplant models where CD4(+) T cells are
necessary for rejection. When CD8(+) T cells are sufficient to mediate rej
ection, these approaches fail, resulting in costimulation blockade-resistan
t rejection. To address this problem we examined the role of lymphotoxin-re
lated molecules in CD8(+) T cell-mediated rejection of murine intestinal al
lografts. Targeting membrane lymphotoxin by means of a fusion protein, mAb,
or genetic mutation inhibited rejection of intestinal allografts by CD8(+)
T cells. This effect was associated with decreased monokine induced by IFN
-gamma (Mig) and secondary lymphoid chemokine (SLC) gene expression within
allografts and spleens respectively. Blocking membrane lymphotoxin did not
inhibit rejection mediated by CD4(+) T cells. Combining disruption of membr
ane lymphotoxin and treatment with CTLA4-Ig inhibited rejection in wild-typ
e mice. These data demonstrate that membrane lymphotoxin is an important re
gulatory molecule for CD8(+) T cells mediating rejection and suggest a stra
tegy to avoid costimulation blockade-resistant rejection.